Activation of swine peripheral blood lymphocytes with human recombinant interleukin-2.
These studies examined the effect of the lymphokine interleukin-2 (IL-2) on porcine peripheral blood lymphocytes (PBL). Cultures of porcine (Yorkshire) PBL in human recombinant (r) IL-2 had a time-dependent increase in activation of killer cells. Previous reports of porcine killer cells derived from PBL indicated maximal lysis 18 hr after killer and target cells were mixed, with very little lytic activity at 4 hr. After culturing for 2 days in rIL-2, the cells acquire enhanced lytic capabilities resulting in substantial target lysis in the 4-hr assay. Enhanced lytic activity in the 18 hr assay occurs as early as 30 min after exposure to rIL-2, with a more significant increase after 2 days' exposure. The IL-2-treated cells have an increase in the incorporation of tritiated thymidine and an increase in percentage of granular cells. Tumour targets, such as Daudi, which are resistant to lysis, and L929, Mdt4 and P815, which are moderately susceptible to lysis by untreated swine PBL, had a substantial increase in lysis in IL-2-treated swine PBL. These results indicate human rIL-2 induces functional and morphological changes in swine peripheral blood lymphocytes.
Bhagyam
R C
RC
Pennsylvania State University, Department of Veterinary Science, University Park 16802.
Jarrett-Zaczek
D
D
Ferguson
F G
FG
D000818:Animals; D002455:Cell Division; D003602:Cytotoxicity, Immunologic; D004306:Dose-Response Relationship, Immunologic; D006801:Humans; D007376:Interleukin-2 / Q000494:pharmacology*; D007694:Killer Cells, Natural / Q000276:immunology; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000166:cytology; D009369:Neoplasms / Q000276:immunology; D013552:Swine / Q000276:immunology*
D007376:Interleukin-2